Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Breast Cancer Res Treat. 2011 Jan 1;128(1):229–236. doi: 10.1007/s10549-010-1323-z

Table 3.

Association of micronutrient intake with all-cause (N = 525) and breast cancer (N = 137) survival, CWLS

Micronutrient intake (quintiles)
1 2 3 4 5 P-trend

Vitamin A (IU/d)a 4816 8070 10939 14453 21857
    All-cause survival HR (95% CI)b Ref 0.97 (0.75–1.27) 1.00 (0.76–1.32) 1.05 (0.79–1.40) 1.12 (0.84–1.50) 0.38
    Breast cancer survival HR (95% CI)b Ref 1.40 (0.82–2.40) 1.19 (0.67–2.12) 1.18 (0.66–2.12) 1.24 (0.68–2.24) 0.74
Carotenoids
  α-Carotene (µg/d)a 206 406 582 864 1752
    All-cause survival HR (95% CI)b Ref 1.10 (0.85–1.42) 0.97 (0.74–1.29) 0.94 (0.70–1.27) 1.08 (0.81–1.43) 0.98
    Breast cancer survival HR (95% CI)b Ref 0.93 (0.57–1.50) 0.63 (0.36–1.09) 0.54 (0.30–0.99) 0.98 (0.59–1.64) 0.43
  β-Carotene (µg/d)a 1610 2549 3644 5156 8570
    All-cause survival HR (95% CI)b Ref 0.98 (0.75–1.28) 1.25 (0.95–1.64) 1.05 (0.79–1.40) 1.17 (0.88–1.57) 0.25
    Breast cancer survival HR (95% CI)b Ref 1.06 (0.63–1.81) 1.00 (0.58–1.73) 0.93 (0.52–1.65) 1.05 (0.60–1.86) 0.97
  β-Cryptoxanthin (µg/d)a 45 99 170 228 329
    All-cause survival HR (95% CI)b Ref 1.06 (0.79–1.41) 1.18 (0.89–1.56) 1.18 (0.89–1.57) 1.25 (0.93–1.68) 0.11
    Breast cancer survival HR (95% CI)b Ref 0.56 (0.32–1.00) 1.22 (0.75–1.99) 0.77 (0.44–1.34) 0.81 (0.45–1.45) 0.82
  Lutein/Zeaxanthin (µg/d)a 995 1543 2174 2950 4591
    All-cause survival HR (95% CI)b Ref 0.99 (0.75–1.30) 0.98 (0.74–1.29) 1.31 (0.99–1.74) 1.05 (0.77–1.43) 0.26
    Breast cancer survival HR (95% CI)b Ref 1.25 (0.71–2.21) 0.99 (0.54–1.81) 1.38 (0.78–2.46) 1.16 (0.62–2.19) 0.56
  Lycopene (µg/d)a 2102 3908 4734 6222 11479
    All-cause survival HR (95% CI)b Ref 0.93 (0.72–1.21) 1.08 (0.83–1.41) 0.98 (0.73–1.31) 1.11 (0.83–1.47) 0.47
    Breast cancer survival HR (95% CI)b Ref 0.72 (0.39–1.34) 1.08 (0.61–1.91) 0.89 (0.49–1.63) 1.42 (0.80–2.50) 0.11
Fiber (g/d)a 11 15 19 23 30
    All-cause survival HR (95% CI)b Ref 1.00 (0.77–1.32) 0.79 (0.58–1.08) 0.96 (0.69–1.32) 0.75 (0.52–1.09) 0.17
    Breast cancer survival HR (95% CI)b Ref 0.92 (0.55–1.56) 0.65 (0.35–1.18) 0.62 (0.33–1.17) 0.75 (0.38–1.49) 0.24
  Whole grains (g/d) 7 16 26 37 57
    All-cause survival HR (95% CI)b Ref 1.03 (0.79–1.33) 1.05 (0.80–1.37) 0.98 (0.74–1.30) 0.79 (0.59–1.08) 0.20
    Breast cancer survival HR (95% CI)b Ref 0.96 (0.58–1.60) 1.16 (0.70–1.92) 0.66 (0.37–1.20) 0.83 (0.46–1.48) 0.30
Calcium (mg/d)a 622 947 1302 1735 4108
    All-cause survival HR (95% CI)b Ref 0.81 (0.62–1.05) 0.98 (0.75–1.28) 0.96 (0.73–1.27) 0.74 (0.53–1.02) 0.32
    Breast cancer survival HR (95% CI)b Ref 0.80 (0.48–1.34) 0.84 (0.50–1.44) 0.70 (0.40–1.23) 0.59 (0.32–1.08) 0.09
Vitamin D (mg/d)a 81 190 438 558 826
    All-cause survival HR (95% CI)b Ref 1.02 (0.79–1.32) 0.87 (0.66–1.14) 1.00 (0.77–1.33) 0.86 (0.64–1.16) 0.35
    Breast cancer survival HR (95% CI)b Ref 1.03 (0.60–1.76) 0.96 (0.55–1.66) 1.08 (0.63–1.86) 1.02 (0.58–1.79) 0.90
a

Median intake within each quintile. Includes intake from diet and supplements.

b

Hazard ratio (95% confidence interval) adjusted for factors at diagnosis (age, state of residence, menopausal status, smoking, breast cancer stage, alcohol, history of hormone replacement therapy), interval between diagnosis and diet assessment, and factors at follow-up (energy intake, breast cancer treatment, body mass index, and physical activity).